Shigemi Yoshihara Selected Research

tulobuterol

5/2012	Effects of the tulobuterol patch on the treatment of acute asthma exacerbations in young children.
5/2012	Effects of the tulobuterol patch on the treatment of acute asthma exacerbations in young children.
1/2010	Comparative study of skin permeation profiles between brand and generic tulobuterol patches.
6/2006	The use of patch formulation of tulobuterol, a long-acting beta2-adrenoreceptor agonist, in the treatment of severe pediatric asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shigemi Yoshihara Research Topics

Disease

30	Asthma (Bronchial Asthma) 05/2021 - 02/2004
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 02/2004
4	Respiratory Sounds (Crackle) 01/2017 - 08/2009
3	Hypersensitivity (Allergy) 05/2021 - 01/2011
3	Infections 05/2021 - 01/2006
3	Inflammation (Inflammations) 01/2021 - 03/2009
2	Duodenal Ulcer (Curling's Ulcer) 07/2022 - 06/2022
2	Abdominal Pain (Pain, Abdominal) 06/2022 - 01/2021
2	Ulcerative Colitis 11/2021 - 01/2021
2	Autism Spectrum Disorder 01/2021 - 02/2020
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 01/2021
2	Autistic Disorder (Autism) 02/2020 - 01/2019
2	Tuberous Sclerosis (Bourneville's Disease) 02/2020 - 01/2019
2	Neurogenic Inflammation 09/2005 - 05/2005
1	Gastritis 06/2022
1	Overweight 03/2022
1	Obesity 03/2022
1	Atherosclerosis 03/2022
1	Exercise-Induced Allergies 01/2022
1	Acute Generalized Exanthematous Pustulosis 10/2021
1	Vitamin D Deficiency 05/2021
1	Chronic Cough 05/2021
1	Cough-Variant Asthma 05/2021
1	Bronchiectasis 05/2021
1	Cough 05/2021
1	Gastroesophageal Reflux (GERD) 05/2021
1	Heart Failure 05/2021
1	Neoplasms (Cancer) 05/2021
1	Sinusitis 05/2021
1	Pulmonary Tuberculosis 05/2021
1	Chronic Bronchitis 05/2021
1	Lung Injury 05/2021
1	Phobic Disorders (Phobia) 04/2021
1	Oliguria 04/2021
1	Type IV Ehlers-Danlos Syndrome 04/2021
1	Bronchiolitis Obliterans 01/2021
1	Crohn Disease (Crohn's Disease) 01/2021
1	Pediatric Crohn's disease 01/2021
1	Sclerosing Cholangitis 01/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Cholangitis 01/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 02/2020
1	Respiratory Paralysis 02/2020
1	Guillain-Barre Syndrome 02/2020

Drug/Important Bio-Agent (IBA)

6	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2021 - 02/2010
4	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2021 - 09/2012
4	suplatast tosilateIBA 06/2014 - 10/2007
4	tulobuterolIBA 05/2012 - 06/2006
3	Pharmaceutical PreparationsIBA 05/2021 - 01/2010
3	AntioxidantsIBA 01/2021 - 01/2019
3	Fluticasone (Cutivate)FDA LinkGeneric 01/2019 - 10/2015
3	Cannabinoid Receptor AgonistsIBA 01/2010 - 05/2005
2	SteroidsIBA 04/2021 - 10/2017
2	trans-sodium crocetinate (crocetin)IBA 02/2020 - 01/2019
2	Everolimus FDA Link 02/2020 - 01/2019
2	oxidized low density lipoproteinIBA 02/2020 - 01/2019
2	Transferrin (beta 2 Transferrin)IBA 02/2020 - 01/2019
2	Oxidants (Oxidizing Agents)IBA 02/2020 - 01/2019
2	Ceruloplasmin (Ferroxidase)IBA 02/2020 - 01/2019
2	Immunoglobulin E (IgE)IBA 01/2020 - 10/2015
2	Salmeterol Xinafoate (Serevent)FDA Link 01/2019 - 07/2016
2	Bronchodilator Agents (Bronchodilators)IBA 09/2017 - 01/2010
2	Omalizumab (Xolair)FDA Link 01/2017 - 10/2015
2	Palivizumab FDA Link 01/2017 - 11/2013
2	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 01/2010 - 05/2005
2	EndotoxinsIBA 03/2006 - 01/2006
1	Proton Pump InhibitorsIBA 07/2022
1	Interleukin-5 (Interleukin 5)IBA 06/2022
1	25-hydroxyvitamin DIBA 03/2022
1	hydroxide ionIBA 03/2022
1	gluteninIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Mesalamine (Mesalazine)FDA LinkGeneric 11/2021
1	Chemokine CCL17IBA 10/2021
1	Fibroblast Growth Factor-23IBA 05/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2021
1	Blood Proteins (Serum Proteins)IBA 04/2021
1	CollagenIBA 04/2021
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2021
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2021
1	Free RadicalsIBA 01/2021
1	Biological ProductsIBA 01/2021
1	Ustekinumab (CNTO 1275)FDA Link 01/2021
1	C-Reactive ProteinIBA 01/2021
1	EnzymesIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 12/2020
1	CopperIBA 02/2020
1	IronIBA 02/2020
1	CreatineIBA 02/2020
1	MucinsIBA 01/2020
1	AllergensIBA 01/2020
1	SmokeIBA 01/2020
1	AntibodiesIBA 01/2020

Therapy/Procedure

7	Therapeutics 01/2021 - 08/2008
2	Lung Transplantation 01/2021 - 07/2010
1	Tracheostomy 02/2020
1	Artificial Respiration (Mechanical Ventilation) 02/2020